The Biotech Bull Market: Just Hold the Course and Let Profits Ride… Update 1
Rayno Life Science: Mid-Day Movers - IBB down 0.9% UP Diagnostics and Tools: Cepheid (CPHD) up 2.55%.Hologic (HOLX) up 3.7%, Response Genetics (RGDX) up 3.2% Biopharmaceuticals: Array (ARRY) up 12.7%, Astex (ASTX) up 2.2%, Viropharma (VPHM) up 1.12% DOWN Alkermes (ALKS) down 4.8%, Alexion...
Watch For Sell-Off Tomorrow-Caution Urged Update 1 7/19
7/19 11:45a EDT Update -Correction Limited to Techs, Biotechs Surge Tech correction continues with XLK down 1.5% but more money finding its way into biotech "bubblet" with IBB ($195) up 1.6%.Leading sectors are energy, healthcare and industrial with S&P recovering to flatline. Rayno...
Life Science Mutual Funds and ETFs: Up 30-46% 2013 YTD
"1,2,3 Click" -Investing in Life Sciences The bull market in biotech is big and broad enough to make everyone look good and one fund or ETF can "deliver alpha" without exhaustive research or stock picking. Because institutions drive the sector it is elastic enough to feed on itself-"rising tide...
Biotech Stocks Have A Bit of a MO-Off Day: AEGR, PCYC, MDVN, REGN
Biotech Stocks Take A Breather: NASDAQ off 0.3% at 3597 A little profit taking has set in after it seemed that the market would roar all summer. From the action in mid-cap biopharma stocks it looks like hedge funds are taking some off among high flyers.NASDAQ has been up for 14 straight days or...
Biotech Funds and ETFS:JNGLX,FBDIX,FBIOX
See This Week's issue of Barron's (JY 15 p 31) for a good summary of the biotech sector. See also our article at bottom of page from Investor Uprising in 2011.We have covered many ETFs and funds over the years and have favored Fidelity Select Biotechnology Fund (FBIOX) and ETFs such as IBB...